19 related articles for article (PubMed ID: 27671477)
1. Computational Amendment of Parenteral In Situ Forming Particulates' Characteristics: Design of Experiment and PBPK Physiological Modeling.
El Hoffy NM; Yacoub AS; Ghoneim AM; Ibrahim M; Ammar HO; Eissa N
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896273
[TBL] [Abstract][Full Text] [Related]
2. Polymeric and Non Polymeric Injectable In-situ Forming Implant Systems for Sustained Delivery of Lornoxicam: In vitro and In vivo Evaluation.
Yehia SA; Halim SAA; Aziz MY
Curr Drug Deliv; 2018; 15(8):1193-1203. PubMed ID: 29557743
[TBL] [Abstract][Full Text] [Related]
3. Development of Biodegradable Injectable In situ Forming Implants for Sustained Release of Lornoxicam.
Christian R; Thakkar V; Patel T; Gohel M; Baldaniya L; Shah P; Pandya T; Gandhi T
Curr Drug Deliv; 2019; 16(1):66-78. PubMed ID: 30264681
[TBL] [Abstract][Full Text] [Related]
4. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
5. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
Kranz H; Bodmeier R
Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
[TBL] [Abstract][Full Text] [Related]
6. Non-ionic Surfactant Based In Situ Forming Vesicles as Controlled Parenteral Delivery Systems.
Ammar HO; Ibrahim M; Mahmoud AA; Shamma RN; El Hoffy NM
AAPS PharmSciTech; 2018 Apr; 19(3):1001-1010. PubMed ID: 29110291
[TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of injectable in situ forming microparticles for sustained delivery of lornoxicam.
Yehia SA; Abdel-Halim SA; Aziz MY
Drug Dev Ind Pharm; 2017 Feb; 43(2):319-328. PubMed ID: 27671477
[TBL] [Abstract][Full Text] [Related]
8. Clinically established biodegradable long acting injectables: An industry perspective.
Nkanga CI; Fisch A; Rad-Malekshahi M; Romic MD; Kittel B; Ullrich T; Wang J; Krause RWM; Adler S; Lammers T; Hennink WE; Ramazani F
Adv Drug Deliv Rev; 2020 Dec; 167():19-46. PubMed ID: 33202261
[TBL] [Abstract][Full Text] [Related]
9. In Situ Forming Depot as Sustained-Release Drug Delivery Systems.
Kanwar N; Sinha VR
Crit Rev Ther Drug Carrier Syst; 2019; 36(2):93-136. PubMed ID: 30806210
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
